Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sphingomyelin phosphodiesterase 4B, pseudogene (SMPD4BP)
- Target
- SMPD4BP
- Molecular classification
- Other (Pseudogene)
01
Overview
Sphingomyelin phosphodiesterase 4B, pseudogene (SMPD4BP), is classified as a pseudogene, which means it is a non-functional genetic element derived from the original sphingomyelin phosphodiesterase 4 gene family[4]. As a pseudogene, SMPD4BP does not produce a functional protein, and there are no known associated biological functions, disease roles, or drug interactions specific to this locus. Pseudogenes in general can play regulatory roles through RNA-based mechanisms, such as microRNA sponges or competing endogenous RNAs, but there are no specific reports detailing such functions for SMPD4BP[1][3]. SMPD4BP is not considered a therapeutic target, receptor, enzyme, transporter, or similar molecule, and its gene status (pseudogene) implies it does not fulfill the functional roles expected of typical drug targets[4].
- Other names
- SMPD4BPNeutral sphingomyelinase-3 pseudogeneSphingomyelin phosphodiesterase 4, neutral membrane (neutral sphingomyelinase-3) pseudogene
02
Biological functions
Other (No known direct biological function as a protein-coding gene)
03
Disease associations
Other (No direct disease role; general pseudogene functions may apply)
Beyond the preview
Go deeper on Sphingomyelin phosphodiesterase 4B, pseudogene (SMPD4BP).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sphingomyelin phosphodiesterase 4B, pseudogene (SMPD4BP).